In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…
White Paper
In this white paper, you’ll learn more about how PRA is meeting the demands of the dynamic clinical research industry by supplying the next…
Blog
January is Cervical Cancer Awareness Month. In light of this, we share some of the most recent highlights of cervical cancer research.
White Paper
Innovative biotech products present a complex regulatory environment. For this reason, a formidable regulatory strategist is a critical member of the…
Blog
Anjanette Elligan, Clinical Site Operations Manager, reminds us the importance of recognizing each other’s humanity and embracing our diversity.
Blog
In Part Three of our Decoding FDA Gene Therapy Guidances series, we discuss the need for thorough long-term follow-up studies for these products, as…
Blog
In Part Two of Decoding FDA Gene Therapy Guidances, we discuss three separate guidances that provide further insight into how sponsors can safely and…
Blog
In Part One of our Decoding FDA Gene Therapy Guidances series, we discuss the significance of several new FDA guidances regarding human gene therapy…
Blog
From telemedicine to decentralized clinical trials to artificial intelligence and beyond, the COVID-19 crisis has kicked the use of technology in the…
Fact Sheet
Pharmacogenomics aims to develop rational means to optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency…
White Paper
Glaucoma remains a chronic and visually debilitating disease that has vast public health implications, as well as pronounced effects on individual…